The mechanism underlying acetaminophen-induced hepatotoxicity in humans and mice involves mitochondrial damage and

Mitchell R McGill1, Matthew R Sharpe, C David Williams

  • 1Department of Pharmacology, Toxicology, and Therapeutics, University of Kansas Medical Center, Kansas City, Kansas 66160, USA.

Insights

Acetaminophen overdose causes liver failure through mitochondrial damage and DNA fragmentation. These events, identified by biomarkers in patient plasma, lead to necrotic cell death, not apoptosis.

Area of Science:

  • Hepatology
  • Toxicology
  • Biochemistry

Background:

  • Acetaminophen (APAP) overdose is a leading cause of acute liver failure in the US.
  • APAP toxicity involves a reactive metabolite, mitochondrial dysfunction, and DNA fragmentation in rodents.
  • Human APAP toxicity mechanisms, particularly downstream events, remain under-investigated.

Purpose of the Study:

  • To investigate biomarkers of mitochondrial damage and nuclear DNA fragmentation in human acetaminophen overdose.
  • To determine if acetaminophen overdose induces apoptosis or necrosis in human liver injury.
  • To correlate plasma biomarker levels with the extent of hepatic injury.

Main Methods:

  • Measured plasma glutamate dehydrogenase (GDH), mitochondrial DNA (mtDNA), and nuclear DNA fragments in APAP-overdose patients.
  • Compared biomarker levels between patients with abnormal liver function tests (LTs) and a normal LT control group, plus healthy volunteers.
  • Conducted parallel studies in mice and analyzed caspase-3 activity to differentiate cell death pathways.

Main Results:

  • Elevated plasma GDH activity and mtDNA concentration in patients with abnormal LTs.
  • Increased plasma nuclear DNA fragmentation in the abnormal LT cohort compared to controls.
  • Plasma biomarkers correlated with tissue injury in mice; caspase-3 was not elevated, indicating necrosis, not apoptosis.

Conclusions:

  • Mitochondrial damage and nuclear DNA fragmentation are critical events in human APAP hepatotoxicity.
  • These events likely result in necrotic cell death, consistent with rodent models.
  • Plasma biomarkers can reflect the severity of APAP-induced liver injury.

Related Concept Videos

Bioactivation and Tissue Toxicity01:25

Bioactivation and Tissue Toxicity

Bioactivation is a metabolic process that transforms less reactive substances into highly reactive metabolites, initiating tissue toxicity. This transformation can lead to various toxic effects, including carcinogenesis and teratogenesis. Reactive metabolites are classified into two main types: electrophiles and free radicals.Electrophiles are electron-deficient species and are produced primarily by the enzyme cytochrome P-450 during the metabolism of compounds containing carbon, nitrogen, or...
Drug Toxicity: Dose-Dependent Reactions01:24

Drug Toxicity: Dose-Dependent Reactions

Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase01:27

Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase

Phase II biotransformation reactions are essential for detoxifying and eliminating xenobiotics, including many pharmaceutical compounds. These reactions typically involve conjugation, the covalent attachment of polar endogenous groups such as glucuronic acid, sulfate, methyl, or acetyl moieties to functional groups introduced during Phase I metabolism. The resulting conjugates are more water-soluble, enabling efficient renal or biliary excretion.The major classes of Phase II enzymes include...
Phase II Reactions: Acetylation Reactions01:24

Phase II Reactions: Acetylation Reactions

Acetylation, a phase II biotransformation reaction, introduces an acetyl group to drugs or their metabolites. Acetyltransferase enzymes facilitate this reaction, which resembles α-amino acid conjugation due to the addition of a functional group to the drug molecule.
The substrates for acetylation are typically drugs or their metabolites with an amino, sulfonamide, or hydrazine functional group. Acetylation can occur at several points in the drug molecule, including primary, secondary, and...
Phase II Reactions: Glutathione Conjugation and Mercapturic Acid Formation01:22

Phase II Reactions: Glutathione Conjugation and Mercapturic Acid Formation

Glutathione, a tripeptide made up of glutamate, cysteine, and glycine, is a critical player in the detoxification of drugs and xenobiotics via a process known as glutathione conjugation or mercapturic acid formation. This phase II biotransformation reaction involves the covalent binding of glutathione to a drug or its metabolite, enhancing the compound's water solubility and enabling its excretion.
Several distinctive characteristics distinguish glutathione conjugation from other phase II...
Acute Pancreatitis II: Pathophysiology01:21

Acute Pancreatitis II: Pathophysiology

The pathophysiology of acute pancreatitis centers on injury to pancreatic acinar cells, which initiates a cascade of harmful intracellular events.This injury leads to premature activation of trypsinogen to trypsin in the pancreas. Trypsin then activates other digestive enzymes, such as chymotrypsin, elastase, and phospholipase A2, which begin breaking down pancreatic tissue. The resulting autodigestion causes local inflammation, tissue swelling, hemorrhage, and fat necrosis.Injured acinar cells...